Archive: portfolio recommendation


Behind the Pick: Phoenix PharmaLabs

By Early Investing on March 25, 2019

First Stage Investor Co-Founder Andy Gordon takes a deeper dive into why he likes Phoenix Pharma Labs so much and the "X" factor that put them over the top.
This week, we’re checking in with two of our portfolio companies. HyperSciences is planning a big field test of its technology, while 20/20 GeneSystems is expanding its reach.